Cambridge Investment Research Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$468K	Sell	10,747 -1,144	-10%	-$45.1K	﹤0.01%	3029
2026 Q1	$397K	Sell	11,891 -413	-3%	-$15.3K	﹤0.01%	3014
2025 Q4	$428K	Sell	12,304 -1,339	-10%	-$49.4K	﹤0.01%	2872
2025 Q3	$510K	Sell	13,643 -14	-0.1%	-$484	﹤0.01%	2666
2025 Q2	$444K	Sell	13,657 -256	-2%	-$7.31K	﹤0.01%	2652
2025 Q1	$375K	Sell	13,913 -16,283	-54%	-$478K	﹤0.01%	2683
2024 Q4	$863K	Buy	30,196 +8,886	+42%	+$258K	﹤0.01%	1985
2024 Q3	$573K	Buy	21,310 +786	+4%	+$20.7K	﹤0.01%	2297
2024 Q2	$570K	Sell	20,524 -2,190	-10%	-$59.7K	﹤0.01%	2190
2024 Q1	$628K	Sell	22,714 -800	-3%	-$20.9K	﹤0.01%	2074
2023 Q4	$573K	Sell	23,514 -1,947	-8%	-$44.3K	﹤0.01%	2084
2023 Q3	$570K	Sell	25,461 -1,310	-5%	-$31.6K	﹤0.01%	1973
2023 Q2	$685K	Sell	26,771 -1,048	-4%	-$24.8K	﹤0.01%	1895
2023 Q1	$658K	Buy	27,819 +295	+1%	+$6.78K	﹤0.01%	1897
2022 Q4	$601K	Sell	27,524 -1,776	-6%	-$43.8K	﹤0.01%	1879
2022 Q3	$716K	Sell	29,300 -524	-2%	-$14.5K	﹤0.01%	1702
2022 Q2	$801K	Sell	29,824 -905	-3%	-$29.1K	﹤0.01%	1628
2022 Q1	$1.2M	Sell	30,729 -11,071	-26%	-$430K	0.01%	1445
2021 Q4	$1.92M	Sell	41,800 -653	-2%	-$31.2K	0.01%	1169
2021 Q3	$2.01M	Buy	42,453 +16,634	+64%	+$777K	0.01%	1097
2021 Q2	$1.2M	Buy	+25,819	New	+$1.17M	0.01%	1405
2021 Q1	–	Sell	-38,542	Closed	-$1.58M	–	2907
2020 Q4	$1.58M	Buy	38,542 +7,265	+23%	+$283K	0.01%	1052
2020 Q3	$1.17M	Sell	31,277 -18,237	-37%	-$672K	0.01%	1101
2020 Q2	$1.7M	Sell	49,514 -4,574	-8%	-$142K	0.01%	845
2020 Q1	$1.51M	Sell	54,088 -27,641	-34%	-$920K	0.01%	779
2019 Q4	$2.84M	Buy	81,729 +10,057	+14%	+$340K	0.02%	645
2019 Q3	$2.31M	Sell	71,672 -24,735	-26%	-$846K	0.02%	685
2019 Q2	$3.31M	Buy	96,407 +23,080	+31%	+$778K	0.03%	540
2019 Q1	$2.46M	Buy	73,327 +10,755	+17%	+$338K	0.02%	636
2018 Q4	$1.73M	Buy	62,572 +7,451	+14%	+$231K	0.02%	687
2018 Q3	$2.12M	Buy	55,121 +11,619	+27%	+$427K	0.02%	669
2018 Q2	$1.53M	Buy	43,502 +5,946	+16%	+$207K	0.02%	759
2018 Q1	$1.25M	Buy	37,556 +12,624	+51%	+$430K	0.01%	826
2017 Q4	$827K	Buy	24,932 +13,497	+118%	+$448K	0.01%	1003
2017 Q3	$362K	Buy	+11,435	New	+$338K	﹤0.01%	1444
2016 Q1	–	Sell	-19,290	Closed	-$428K	–	1616
2015 Q4	$428K	Buy	+19,290	New	+$442K	0.01%	925

Other funds holding FFTY

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $171M AUM 36.85% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return

Cambridge Investment Research Advisors's FFTY Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its CapForce IBD 50 ETF (FFTY) stake by 9.6% in Q2 2026, selling an estimated $45.1K and leaving 10,747 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #3029.

Cambridge Investment Research Advisors first reported a position in FFTY in Q4 2015 and has held it in 36 quarters since. The position peaked at $3.31M in Q2 2019. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

Cambridge Investment Research Advisors held 10,747 shares of CapForce IBD 50 ETF worth $468K as of Q2 2026.
Cambridge Investment Research Advisors sold 1,144 CapForce IBD 50 ETF shares in Q2 2026, an estimated $45.1K.
CapForce IBD 50 ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3029 holding.
Cambridge Investment Research Advisors first reported a position in CapForce IBD 50 ETF in Q4 2015 and has held it in 36 quarters since.
Cambridge Investment Research Advisors's CapForce IBD 50 ETF position peaked at $3.31M in Q2 2019.
33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.